Activities of Newer Fluoroquinolones against Streptococcus pneumoniae Clinical Isolates Including Those with Mutations in the gyrA, parC, and parELoci

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  1999-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/AAC.43.2.329PMID 9925527PMCID PMC89072
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interscience Conference on Antimicrobial Agents and Chemotherapy

  2001cited by this paper
• Performance standards for antimicrobial susceptibility testing

  2001cited by this paper
• Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard

  2000cited by this paper
• Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard

  2000cited by this paper
• Efficacy of Trovafloxacin against Penicillin-Susceptible and Multiresistant Strains of Streptococcus pneumoniae in a Mouse Pneumonia Model

  1998cited by this paper
• Molecular Characterization of the Gene Encoding the DNA Gyrase A Subunit of Streptococcus pneumoniae

  1998cited by this paper
• Targeting of DNA gyrase in Streptococcus pneumoniae by sparfloxacin: selective targeting of gyrase or topoisomerase IV by quinolones

  1997cited by this paper
• Multistaie population-based assessment of drug resistant S. pneumoniae mortality

  1997cited by this paper
• Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. The Laboratory Investigator Group.

  1997cited by this paper
• Characterization of a mutation in the parE gene that confers fluoroquinolone resistance in Streptococcus pneumoniae

  1997influential reference
• Therapy and outcomes of meningitis caused by drug-resistant Streptococcus pneumoniae (SP) in three U.S. cities, 1994-1996

  1997cited by this paper
• Fluoroquinolone antibacterials: SAR, mechanism of action, resistance, and clinical aspects

  1996cited by this paper
• Canadian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae. Canadian Bacterial Surveillance Network

  1996cited by this paper
• Contribution of mutations in gyrA and parC genes to fluoroquinolone resistance of mutants of Streptococcus pneumoniae obtained in vivo and in vitro

  1996cited by this paper
• High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrA

  1996influential reference
• The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System.

  1996cited by this paper
• Antimicrobial resistance among lower respiratory tract isolates of Streptococcus pneumoniae: results of a 1992-93 western Europe and USA collaborative surveillance study. The Alexander Project Collaborative Group.

  1996cited by this paper
• Activity of the new fluoroquinolone trovafloxacin (CP-99,219) against DNA gyrase and topoisomerase IV mutants of Streptococcus pneumoniae selected in vitro

  1996cited by this paper
• Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study

  1996cited by this paper
• In-vitro susceptibility of Streptococcus pneumoniae to the d- and l-isomers of ofloxacin: interpretive criteria and quality control limits.

  1996cited by this paper
• Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae

  1996influential reference
• Cloning and characterization of the parC and parE genes of Streptococcus pneumoniae encoding DNA topoisomerase IV: role in fluoroquinolone resistance

  1996influential reference
• ParC subunit of DNA topoisomerase IV of Streptococcus pneumoniae is a primary target of fluoroquinolones and cooperates with DNA gyrase A subunit in forming resistance phenotype

  1996influential reference
• Antimicrobial resistance among lower respiratory tract isolates of Streptococcus pneumoniae: results of a 1992–93 Western Europe and USA collaborative surveillance study

  1996cited by this paper
• Identification of multiple clones of extended-spectrum cephalosporin-resistant Streptococcus pneumoniae isolates in the United States

  1995cited by this paper
• In Vivo Selection of Streptococcus pneumoniae, Resistant to Quinolones, Including Sparfloxin.

  1995cited by this paper
• Development of interpretive criteria and quality control limits for broth microdilution and disk diffusion antimicrobial susceptibility testing of Streptococcus pneumoniae

  1994cited by this paper
• In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. Medical Centers in 1992 and 1993

  1994cited by this paper
• Emergence of drug-resistant pneumococcal infections in the United States.

  1994cited by this paper
• Nucleotide sequence of the Staphylococcus aureus gyrB-gyrA locus encoding the DNA gyrase A and B proteins

  1992cited by this paper
• National Committee for Clinical Laboratory Standards.

  1980cited by this paper

• Invasive Streptococcus suis isolated in Spain contain a highly promiscuous and dynamic resistome

  2024cites this paper
• Streptococcus pneumoniae favors tolerance via metabolic adaptation over resistance to circumvent fluoroquinolones

  2024cites this paper
• Pneumococcal Evasion of Antibiotics via Metabolic Adaptation During Infection

  2022cites this paper
• Antibiotic Tolerance and Heteroresistance: Associated Fitness Costs and Potential in Evading Antibiotic Killing

  2021cites this paper
• Selected Mutations by Nemonoxacin and Fluoroquinolone Exposure Among Relevant Gram-Positive Bacterial Strains in Taiwan

  2020cites this paper
• The mutational landscape of quinolone resistance in Escherichia coli

  2019cites this paper
• Potential of the fluoroketolide RBx 14255 against Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae in an experimental murine meningitis model.

  2019cites this paper
• NAOSITE : Nagasaki University ' s Academic Output SITE

  2017cites this paper
• In Vitro Resistance Development to Nemonoxacin in Streptococcus pneumoniae: A Unique Profile for a Novel Nonfluorinated Quinolone

  2016cites this paper
• Molecular Analysis of Rising Fluoroquinolone Resistance in Belgian Non-Invasive Streptococcus pneumoniae Isolates (1995-2014)

  2016cites this paper
• Biographical Feature: James Jorgensen, Ph.D

  2015cites this paper
• States 377 Medical Centers throughout the United against Recent Respiratory Isolates from Moxifloxacin and Comparator Agents Benchmarking the In Vitro Activities of

  2014cites this paper
• Molecular Investigation of Quinolone Resistance of Quinolone Resistance-Determining Region in Streptococcus pneumoniae Strains Isolated from Iran Using Polymerase Chain Reaction–Restriction Fragment Length Polymorphism Method

  2014cites this paper
• Regulation of the PatAB efflux pump in Streptococcus pneumoniae

  2014cites this paper
• Genomic Characterization of Ciprofloxacin Resistance in a Laboratory-Derived Mutant and a Clinical Isolate of Streptococcus pneumoniae

  2013cites this paper
• Rapid bactericidal activity of sitafloxacin against Streptococcus pneumoniae.

  2013cites this paper
• pneumoniae and a Clinical Isolate of Streptococcus Resistance in a Laboratory-Derived Mutant Genomic Characterization of Ciprofloxacin

  2013cites this paper
• Clinical and bacteriological efficacies of sitafloxacin against community-acquired pneumonia caused by Streptococcus pneumoniae: nested cohort within a multicenter clinical trial

  2013cites this paper
• Prevalence of clinically relevant antibiotic resistance genes in surface water samples collected from Germany and Australia.

  2012cites this paper
• Levofloxacin

  2012cites this paper
• Levofloxacin

  2012cites this paper
• Characterization of the quinolone resistant determining regions in clinical isolates of pneumococci collected in Canada

  2010cites this paper
• Overexpression of patA and patB, Which Encode ABC Transporters, Is Associated with Fluoroquinolone Resistance in Clinical Isolates of Streptococcus pneumoniae

  2010cites this paper
• In Vitro Activity of Garenoxacin against Streptococcus pneumoniae Mutants with Characterized Resistance Mechanisms

  2009cites this paper
• Frequency of 1st- and 2nd-step topoisomerase mutations in Streptococcus pneumoniae following levofloxacin and moxifloxacin exposure.

  2008cites this paper
• Dual-targeting properties of the 3-aminopyrrolidyl quinolones, DC-159a and sitafloxacin, against DNA gyrase and topoisomerase IV: contribution to reducing in vitro emergence of quinolone-resistant Streptococcus pneumoniae.

  2008cites this paper
• Optimizing Use of Quinolones in the Critically Ill

  2007cites this paper
• parE mutations in Streptococcus pneumoniae may reduce bactericidal activity of respiratory fluoroquinolones.

  2007cites this paper
• Selection of quinolone resistance in Streptococcus pneumoniae exposed in vitro to subinhibitory drug concentrations.

  2007cites this paper
• Mutations and Mutation Rate in the Development of Fluoroquinolone Resistance

  2007cites this paper
• In Vitro Activity of DC-159a, a New Broad-Spectrum Fluoroquinolone, Compared with That of Other Agents against Drug-Susceptible and -Resistant Pneumococci

  2007influential citation
• Optimizing use of quinolones in the critically ill.

  2007cites this paper
• Emergence and epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae strains from Italy: report from the SENTRY Antimicrobial Surveillance Program (2001-2004).

  2006cites this paper
• Antimicrobial-resistant bacteria in the community setting

  2006cites this paper
• Antipneumococcal Activity of DW-224a, a New Quinolone, Compared to Those of Eight Other Agents

  2006cites this paper
• Effect of Ethanol on Fluoroquinolone Efficacy in a Rat Model of Pneumococcal Pneumonia

  2006cites this paper
• First Characterization of Fluoroquinolone Resistance in Streptococcus suis

  2006cites this paper
• Correlation between in vitro and in vivo activity of levofloxacin and moxifloxacin against pneumococcal strains with different susceptibilities to fluoroquinolones.

  2006cites this paper
• The Bacteriology of Severe Community-Acquired Pneumonia and the Choice of Appropriate Empiric Therapy

  2005cites this paper
• Why Do Some Patients Get Severe Pneumonia

  2005cites this paper
• Activity of the new quinolone WCK 771 against pneumococci.

  2005cites this paper
• Detection of Resistance to Gatifloxacin and Moxifloxacin in Streptococcus pneumoniae with the VITEK 2 Instrument

  2004cites this paper
• Quinolone resistance mechanisms in pneumococci.

  2004cites this paper
• [Molecular epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae in Japan].

  2004cites this paper
• Quinolone resistance among pneumococci: therapeutic and diagnostic implications.

  2004cites this paper
• Gemifloxacin: A New Fluoroquinolone Approved for Treatment of Respiratory Infections

  2004cites this paper
• Comparative study of the in vitro activity of a new fluoroquinolone, ABT-492.

  2004cites this paper
• Levofloxacin-Resistant Invasive Streptococcus pneumoniae in the United States: Evidence for Clonal Spread and the Impact of Conjugate Pneumococcal Vaccine

  2004cites this paper
• Fluoroquinolone Resistance in Clinical Isolates of Streptococcus pneumoniae from Asian Countries: ANSORP Study

  2004cites this paper
• Molekulare Untersuchung der Makrolid-, Tetrazyklin-, Chinolon- und Trimethoprim/Sulfamethoxazol-Resistenzmechanismen bei europäischen Streptococcus pneumoniae Isolaten

  2004influential citation
• Chemistry and biological activities of 1,8-naphthyridines

  2004cites this paper
• Role of Efflux Pumps and Mutations in Genes for Topoisomerases II and IV in Fluoroquinolone-Resistant Pseudomonas aeruginosa Strains

  2003cites this paper
• Mechanisms of quinolone action and microbial response.

  2003cites this paper
• Antipneumococcal Activity of DK-507k, a New Quinolone, Compared with the Activities of 10 Other Agents

  2003cites this paper
• First Streptococcus agalactiae Isolates Highly Resistant to Quinolones, with Point Mutations in gyrA and parC

  2003cites this paper
• In vitro pharmacodynamic activity of gatifloxacin, gemifloxacin, moxifloxacin and levofloxacin against Streptococcus pneumoniae containing specific mutations in DNA gyrase and topoisomerase IV.

  2003cites this paper
• Drug-resistant Streptococcus pneumoniae in community-acquired pneumonia

  2003cites this paper
• Antimicrobial Susceptibility Breakpoints and First-Step parC Mutations in Streptococcus pneumoniae: Redefining Fluoroquinolone Resistance

  2003cites this paper
• Fluoroquinolone-Resistant Streptococcus pneumoniae in Spain: Activities of Garenoxacin against Clinical Isolates Including Strains with Altered Topoisomerases

  2003cites this paper
• Challenges in Antimicrobial Susceptibility Testing and Reporting

  2002cites this paper
• Levofloxacin Treatment Failure in a Patient with Fluoroquinolone‐Resistant Streptococcus pneumoniae Pneumonia

  2002cites this paper
• Activity of Quinolones Against Gram-Positive Cocci: Mechanisms of Drug Action and Bacterial Resistance

  2002cites this paper
• A critical review of the fluoroquinolones: focus on respiratory infections.

  2002cites this paper
• Microbiology of newer fluoroquinolones: focus on respiratory pathogens.

  2002cites this paper
• Topoisomerase Mutations Associated with In Vitro Selection of Resistance to Moxifloxacin in Streptococcus pneumoniae

  2002cites this paper
• Topoisomerase II and IV Quinolone Resistance-Determining Regions in Stenotrophomonas maltophilia Clinical Isolates with Different Levels of Quinolone Susceptibility

  2002cites this paper
• In vitro activity of moxifloxacin against recent community-acquired respiratory tract pathogens isolated in France: a national survey.

  2002cites this paper
• The effect of cephalosporin resistance on mortality in adult patients with nonmeningeal systemic pneumococcal infections.

  2002cites this paper
• Fluoroquinolone Resistance in Streptococcus pneumoniae in United States since 1994-1995

  2002cites this paper
• Widespread use of fluoroquinolones versus emerging resistance in pneumococci.

  2002cites this paper
• A Critical Review of the Fluoroquinolones

  2002influential citation
• Fluoroquinolone-Resistant Streptococcus pneumoniae Strains Occur Frequently in Elderly Patients in Japan

  2002cites this paper
• Expression of Efflux Pump Gene pmrA in Fluoroquinolone-Resistant and -Susceptible Clinical Isolates of Streptococcus pneumoniae

  2002cites this paper
• Prevalence of Single Mutations in Topoisomerase Type II Genes among Levofloxacin-Susceptible Clinical Strains of Streptococcus pneumoniae Isolated in the United States in 1992 to 1996 and 1999 to 2000

  2002cites this paper
• Quinolonas y Streptococcus pneumoniae. Mecanismo de acción y resistencia

  2002cites this paper
• Quinolone resistance: Older concepts and newer developments

  2001cites this paper
• Interspecies Recombination Contributes Minimally to Fluoroquinolone Resistance in Streptococcus pneumoniae

  2001cites this paper
• Mechanisms responsible for cross-resistance and dichotomous resistance among the quinolones.

  2001influential citation
• Molecular Detection of Antimicrobial Resistance

  2001cites this paper
• Quinolone-Resistance Mechanisms and In Vitro Susceptibility Patterns Among European Isolates of Streptococcus mitis, Streptococcus sanguis, and Streptococcus pneumoniae

  2001cites this paper
• Fluoroquinolone Resistance Is a Poor Surrogate Marker for Type II Topoisomerase Mutations in Clinical Isolates ofStreptococcus pneumoniae

  2001cites this paper
• [Therapeutic failure with ceftriaxone in a case of exacerbation of chronic bronchitis by pneumococcus highly resistant to beta-lactams].

  2001cites this paper
• Shigellosis outbreak associated with an unchlorinated fill-and-drain wading pool--Iowa, 2001.

  2001cites this paper
• Development and spread of bacterial resistance to antimicrobial agents: an overview.

  2001cites this paper
• In Vitro Development of Resistance to Six Quinolones in Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus

  2001cites this paper
• Sub-inhibitory concentrations of vancomycin prevent quinolone-resistance in a penicillin-resistant isolate of Streptococcus pneumoniae

  2001cites this paper
• Drug Interactions with Clinafloxacin

  2001cites this paper
• Quinolone molecular structure-activity relationships: what we have learned about improving antimicrobial activity.

  2001cites this paper
• Type II Topoisomerase Mutations in Fluoroquinolone-Resistant Clinical Strains of Pseudomonas aeruginosa Isolated in 1998 and 1999: Role of Target Enzyme in Mechanism of Fluoroquinolone Resistance

  2001cites this paper
• Genetic Analyses of Mutations Contributing to Fluoroquinolone Resistance in Clinical Isolates ofStreptococcus pneumoniae

  2001cites this paper
• Resistant pathogens:Emergence and Control

  2001cites this paper
• Fracaso terapéutico con ceftriaxona en una exacerbación de bronquitis crónica por neumococo altamente resistente a betalactámicos

  2001cites this paper
• New Mutation in ParE in a Pneumococcal In Vitro Mutant Resistant to Fluoroquinolones

  2001cites this paper
• Pharmacokinetics of Clinafloxacin after Single and Multiple Doses

  2001cites this paper
• Gram-Negative Bacteria

  2001cites this paper
• Comparison of antimicrobial in vitro activities against Streptococcus pneumoniae independent of MIC susceptibility breakpoints using MIC frequency distribution curves, scattergrams and linear regression analyses.

  2001cites this paper
• Evaluation of Susceptibility Testing To Detect Fluoroquinolone Resistance Mechanisms in Streptococcus pneumoniae

  2001cites this paper
• Clinafloxacin Pharmacokinetics in Subjects with Various Degrees of Renal Function

  2001cites this paper
• Clinical isolates of Streptococcus pneumoniae resistant to levofloxacin contain mutations in both gyrA and parC genes.

  2001cites this paper
• Analysis of Ciprofloxacin Activity against Streptococcus pneumoniae after 10 Years of Use in the United States

  2000cites this paper